Results
1 -
6 of
6
(Click
here to explore results)
Site-selective modification strategies in antibody–drug conjugates . Stephen J. Walsh, Jonathan D. Bargh, Friederike M. Dannheim, Abigail R. Hanby, Hikaru Seki, Andrew J. Counsell, Xiaoxu Ou, Elaine Fowler, Nicola Ashman, Yuri Takada, Albert Isidro-Llobet, Jeremy S. Parker, Jason S. Carroll, David R. Spring
, Chem. Soc. Rev.
, 2021
, 50
, 1305
Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors . Amr El-Demerdash, Ahmed A. Al-Karmalawy, Tarek Mohamed Abdel-Aziz, Sameh S. Elhady, Khaled M. Darwish, Ahmed H. E. Hassan
, RSC Adv.
, 2021
, 11
, 31339
Impact of dipeptide on ADC physicochemical properties and efficacy identifies Ala–Ala as the optimal dipeptide . Lu Wang, Adrian D. Hobson, Julia Fitzgibbons, Axel Hernandez, Ying Jia, Zhou Xu, Zhongyuan Wang, Yajie Yu, Xiang Li
, RSC Med. Chem.
, 2024
, 15
, 355
Peptides as a platform for targeted therapeutics for cancer: peptide–drug conjugates (PDCs) . Bethany M. Cooper, Jessica Iegre, Daniel H. O' Donovan, Maria Ölwegård Halvarsson, David R. Spring
, Chem. Soc. Rev.
, 2021
, 50
, 1480
Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody–drug conjugates . Min Sun Kang, Theresa Wai See Kong, Joycelyn Yi Xin Khoo, Teck-Peng Loh
, Chem. Sci.
, 2021
, 12
, 13613
Recent advances on marine mollusk-derived natural products: chemistry, chemical ecology and therapeutical potential . Zi-Hui Chen, Yue-Wei Guo, Xu-Wen Li
, Nat. Prod. Rep.
, 2023
, 40
, 509